BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9365453)

  • 21. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
    Martin-Carbonero L; Barrios A; Saballs P; Sirera G; Santos J; Palacios R; Valencia ME; Alegre M; Podzamczer D; González-Lahoz J;
    AIDS; 2004 Aug; 18(12):1737-40. PubMed ID: 15280789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal and cutaneous AIDS-related Kaposi's sarcoma: different activity of liposomal doxorubicin according to location of lesions.
    Hernández-Morales DE; Hernández-Zaccaro AE
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):264-6. PubMed ID: 15952971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirolimus monotherapy for Kaposi's sarcoma in an HIV-negative patient.
    Weenink JJ; Groeneveld JO; de Fijter CW
    Lancet Oncol; 2006 Oct; 7(10):875-6. PubMed ID: 17012050
    [No Abstract]   [Full Text] [Related]  

  • 25. Bilateral eyelid Kaposi's sarcoma in an HIV-negative patient.
    Fernández-Montalvo L; Ibáñez-Flores N; Cifuentes-Canorea P; Castellar-Cerpa J; Graell-Martín X; Cuadrado-Claramonte V
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):606-609. PubMed ID: 30055902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma.
    Bennett CL; Golub RM; Stinson TJ; Aboulafia DM; von Roenn J; Bogner J; Goebel FD; Stewart S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):460-5. PubMed ID: 9715842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal daunorubicin: new preparation. Kaposi's sarcoma: occasional remission.
    Prescrire Int; 1998 Apr; 7(34):41-2. PubMed ID: 10183380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DOXIL approved by FDA.
    AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
    Goebel FD; Goldstein D; Goos M; Jablonowski H; Stewart JS
    Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Kaposi's sarcoma with liposomal doxorubicin.
    Bergin C; O'Leary A; McCreary C; Sabra K; Mulcahy F
    Am J Health Syst Pharm; 1995 Sep; 52(18):2001-4. PubMed ID: 8528867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaposi's sarcoma after renal transplantation: treatment with liposomal doxorubicin.
    Boehringer M; Schwarz A; Keller F
    Nephrol Dial Transplant; 1999 May; 14(5):1342-3. PubMed ID: 10344407
    [No Abstract]   [Full Text] [Related]  

  • 32. Doxil receives FDA market clearance.
    AIDS Patient Care STDS; 1996 Apr; 10(2):135. PubMed ID: 11361702
    [No Abstract]   [Full Text] [Related]  

  • 33. Liposomal doxorubicin in pulmonary Kaposi's sarcoma: improved survival as compared to patients without liposomal doxorubicin.
    Grünaug M; Bogner JR; Loch O; Goebel FD
    Eur J Med Res; 1998 Feb; 3(1-2):13-9. PubMed ID: 9512962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal doxorubicin.
    Linsky KF; Ignoffo RJ
    Cancer Pract; 1996; 4(5):288-90. PubMed ID: 9004577
    [No Abstract]   [Full Text] [Related]  

  • 35. Liposomal KS drugs approved.
    GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.
    Girard PM; Bouchaud O; Goetschel A; Mukwaya G; Eestermans G; Ross M; Rozenbaum W; Saimot AG
    AIDS; 1996 Jun; 10(7):753-7. PubMed ID: 8805866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin in sterically stabilized liposomes.
    Lasic DD
    Nature; 1996 Apr; 380(6574):561-2. PubMed ID: 8606781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin.
    Berry G; Billingham M; Alderman E; Richardson P; Torti F; Lum B; Patek A; Martin FJ
    Ann Oncol; 1998 Jul; 9(7):711-6. PubMed ID: 9739435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of severe Kaposi's sarcoma after initiation of antiretroviral triple therapy.
    Jung C; Bogner JR; Goebel F
    Eur J Med Res; 1998 Sep; 3(9):439-42. PubMed ID: 9737891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
    Simpson JK; Miller RF; Spittle MF
    Clin Oncol (R Coll Radiol); 1993; 5(6):372-4. PubMed ID: 8305358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.